loadpatents
name:-0.019026041030884
name:-0.024484872817993
name:-0.00054001808166504
Bosmans; Jean-Paul Rene Marie Andre Patent Filings

Bosmans; Jean-Paul Rene Marie Andre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bosmans; Jean-Paul Rene Marie Andre.The latest application filed is for "bicyclic benzamides of 3-or-4-substituted 4-(aminomethyl)-piperidine derivatives".

Company Profile
0.18.16
  • Bosmans; Jean-Paul Rene Marie Andre - Rijkevorsel BE
  • BOSMANS; Jean-Paul Rene Marie Andre - Beerse BE
  • Bosmans; Jean-Paul Rene Marie Andre - Rijkeyorsel BE
  • Bosmans; Jean-Paul Rene Marie Andre - Edegem BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT.sub.4-antagonists
Grant 8,334,304 - Bosmans , et al. December 18, 2
2012-12-18
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant 8,318,742 - Bosmans , et al. November 27, 2
2012-11-27
Equilibrative nucleoside transporter ENT1 inhibitors
Grant 8,263,592 - Bosmans , et al. September 11, 2
2012-09-11
Bicyclic Benzamides of 3-Or-4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
App 20120028987 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2012-02-02
Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant 8,063,070 - Bosmans , et al. November 22, 2
2011-11-22
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant 7,790,750 - Bosmans , et al. September 7, 2
2010-09-07
Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
App 20100210657 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2010-08-19
Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT.sub.4-antagonists
Grant 7,732,464 - Bosmans , et al. June 8, 2
2010-06-08
Aminosulfonyl Substituted 4-(Aminomethyl)-Piperidine Benzamides As 5HT 4-Antagonists
App 20100087483 - BOSMANS; Jean-Paul Rene Marie Andre ;   et al.
2010-04-08
Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT.sub.4-antagonists
Grant 7,652,040 - Bosmans , et al. January 26, 2
2010-01-26
4-(aminomethyl)-piperidine benzamides as 5HT.sub.4-antagonists
Grant 7,638,535 - Bosmans , et al. December 29, 2
2009-12-29
5HT.sub.4-antagonistic 4-(aminomethyl)-piperidine benzamides
Grant 7,635,706 - Bosmans , et al. December 22, 2
2009-12-22
Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant RE40,793 - Bosmans , et al. June 23, 2
2009-06-23
Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT.sub.4 antagonists
Grant 7,498,347 - Bosmans , et al. March 3, 2
2009-03-03
Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
App 20070197600 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2007-08-23
4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
Grant 7,205,410 - Bosmans , et al. April 17, 2
2007-04-17
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20070037850 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2007-02-15
5Ht4-antagonistic 4-(aminomethyl)-piperidine benzamides
App 20070032486 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2007-02-08
4-(Aminomethyl)-piperidine benzamides as 5ht4 - antagonists
App 20060281753 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2006-12-14
Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht 4-antagonists
App 20060142339 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2006-06-29
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20060142342 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2006-06-29
Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4 antagonists
App 20060142340 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2006-06-29
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20060142341 - Bosmans; Jean-Paul Rene Marie Andre ;   et al.
2006-06-29
(+)-Norcisapride
App 20040176414 - Heykants, Jozef Jan Pieter ;   et al.
2004-09-09
Gastrokinetic monocyclic benzamides of 3-or 4-substituted 4-(aminoethyl)-piperidine derivatives
Grant 6,750,349 - Bosmans , et al. June 15, 2
2004-06-15
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20040058958 - Bosmans, Jean-Paul Rene Marie Andre ;   et al.
2004-03-25
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant 6,635,643 - Bosmans , et al. October 21, 2
2003-10-21
4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
App 20030181456 - Bosmans, Jean-Paul Rene Marie Andre ;   et al.
2003-09-25
Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20030078427 - Bosmans, Jean-Paul Rene Marie Andre ;   et al.
2003-04-24
4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
Grant 6,544,997 - Bosmans , et al. April 8, 2
2003-04-08
Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
Grant 6,452,013 - Bosmans , et al. September 17, 2
2002-09-17
Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
App 20020086879 - Bosmans, Jean-Paul Rene Marie Andre ;   et al.
2002-07-04
Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
Grant 5,990,159 - Meulemans , et al. November 23, 1
1999-11-23
Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists
Grant 5,674,868 - Van Daele , et al. October 7, 1
1997-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed